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Epigenetic modifications regulate gene expression in the host response to a diverse range
of pathogens. The extent and consequences of epigenetic modification during
macrophage responses to Streptococcus pneumoniae, and the role of pneumolysin, a
key Streptococcus pneumoniae virulence factor, in influencing these responses, are
currently unknown. To investigate this, we infected human monocyte derived
macrophages (MDMs) with Streptococcus pneumoniae and addressed whether
pneumolysin altered the epigenetic landscape and the associated acute macrophage
transcriptional response using a combined transcriptomic and proteomic approach.
Transcriptomic analysis identified 503 genes that were differentially expressed in a
pneumolysin-dependent manner in these samples. Pathway analysis highlighted the
involvement of transcriptional responses to core innate responses to pneumococci
including modules associated with metabolic pathways activated in response to
infection, oxidative stress responses and NFkB, NOD-like receptor and TNF signalling
pathways. Quantitative proteomic analysis confirmed pneumolysin-regulated protein
expression, early after bacterial challenge, in representative transcriptional modules
associated with innate immune responses. In parallel, quantitative mass spectrometry
identified global changes in the relative abundance of histone post translational
modifications (PTMs) upon pneumococcal challenge. We identified an increase in the
relative abundance of H3K4me1, H4K16ac and a decrease in H3K9me2 and H3K79me2
in a PLY-dependent fashion. We confirmed that pneumolysin blunted early transcriptional
responses involving TNF-a and IL-6 expression. Vorinostat, a histone deacetylase
inhibitor, similarly downregulated TNF-a production, reprising the pattern observed with
pneumolysin. In conclusion, widespread changes in the macrophage transcriptionalorg May 2021 | Volume 12 | Article 5732661
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Frontiers in Immunology | www.frontiersin.response are regulated by pneumolysin and are associated with global changes in histone
PTMs. Modulating histone PTMs can reverse pneumolysin-associated transcriptional
changes influencing innate immune responses, suggesting that epigenetic modification
by pneumolysin plays a role in dampening the innate responses to pneumococci.Keywords: histone post translational modifications, Streptococcus pneumoniae, pneumolysin, tumour necrosis
factor, monocyte derived macrophagesINTRODUCTION
Pneumolysin (ply) is one of the key virulence factors of S.
pneumoniae (the pneumococcus), the leading cause of
community-acquired pneumonia (1) and is present in the
majority of clinical isolates causing invasive pneumococcal
disease (IPD) (2, 3). Pneumolysin is a cholesterol-dependent
cytolysin and part of a family of toxins expressed in Gram-
positive bacteria (4). It is a 53 kDa protein that contains four
domains (5). One mechanism of action is through pore
formation (6) but increasingly it is recognized to mediate
additional actions independent of the ability to form pores (7).
In murine models of bacteraemia ply sufficient mutants are
associated with increased lethality compared to ply deficient
mutants, linking the toxin to virulence (8). Furthermore, the
transmission of S. pneumoniae between hosts has been linked to
the presence of inflammation in the nasopharynx and
pneumolysin has been shown to promote inflammation,
increase transmission and foster the survival ex vivo of S.
pneumoniae (9). It has been also suggested that pneumolysin
facilitates blood stream invasion by S. pneumoniae (3). This
highlights its importance as a key virulence factor of S.
pneumoniae due to its role in the transmission of S.
pneumoniae between hosts, in the progression from
nasopharyngeal colonisation to invasive pneumococcal disease,
the stimulation of inflammation and its cytotoxic effects (1).
Pneumolysin has been shown to alter a variety of immune
responses. For example it has been demonstrated to both activate
the classical complement pathway (10) as well as play a role in
complement evasion (11). Pneumolysin has been associated with
stimulation of NRLP3 and potentially other inflammasome
components (12, 13). In human monocytes it is associated
with production of tumour necrosis factor alpha (TNF-a) and
interleukin (IL-)1b (14). Pneumolysin has been shown to be
responsible for the differential expression of multiple genes in
undifferentiated THP-1 cells, a monocytic cell line (15), but its
impact on gene expression in primary macrophages has not been
established in detail. More recently, pneumolysin has been
shown to bind the mannose receptor C type 1 in mouse
alveolar macrophages leading to diminished pro-inflammatory
cytokine release and enhanced bacterial survival (16).
The subversion of the host immune system is one of the key
components of bacterial pathogenesis. Microorganisms can
highjack host gene expression to their benefit (17–19).
Epigenetic mechanisms such as histone post-translational
modifications (PTMs) have been shown to regulate gene
transcription (20, 21). Moreover, they can be modulated by aorg 2number of different bacterial components (22). Experiments
using both Legionella pneumophila (19), and Listeria
monocytogenes (17) have shown that bacterial interaction
with the THP-1 monocytic cell line also modifies histone
PTMs. Furthermore, H. pylori has been shown to alter both
the host epigenome and transcriptome (23). In the case of
Listeria monocytogenes, Listeriolysin O, a pore-forming
cytolysin similar to ply, is secreted causing dephosphorylation
at serine 10 of histone H3 and reduction in the levels of
acetylated H4 in THP-1 cells. In HeLa cells these changes
altered the transcriptional profile, which was associated with
a decrease in IL-6 and other genes involved in innate immune
responses (18). More recently, Streptococcus pneumoniae via
the action of ply was shown to dephosphorylate serine 10 on
Histone H3 mediated by host cell phosphatase PP1 (24). which
in turn led to efficient infection of epithelial cells. Furthermore,
S. pneumoniae has been shown to lead to chromatin
remodelling in an epithelial cell model in a KDM6B
dependent manner (25). This supports the hypothesis that
bacteria alter the epigenetic profile of the host cell as a
strategy for immune subversion, limiting the inflammatory
response to increase their survival.
The consequences of epigenetic changes during acute
bacterial infections are, however, not fully understood. The aim
of this study was to investigate the consequences and mechanism
underpinning the ability of pneumolysin to modulate
translational responses to S. pneumoniae using primary human
macrophages. We found that pneumolysin modulates a broad
range of immune transcriptional responses in macrophages and
differential protein expression analysis also confirmed changes in
key transcriptional modules. Moreover, we identified global
changes in the abundance of histone PTMs in MDMs in a
pneumolysin dependent manner. We illustrate that one key
pneumolysin-regulated immune response, early TNF-a
production is also altered by chemical manipulation of
histone PTMs.MATERIALS AND METHODS
Bacterial Strains
Streptococcus pneumoniae serotype 2 strain D39, the isogenic
pneumolysin-deficient mutant D39-Dply (Dply), which has a
single amino acid substitution in the pneumolysin sequence
generating a STOP codon and the reconstituted mutant ply-
D39-Dply, which expresses ply under an erythromycin promoter,
were kindly obtained from Prof T. Mitchell (University ofMay 2021 | Volume 12 | Article 573266
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previously described (7). Strains were grown in brain heart
infusion broth and 20% FCS to mid exponential phase (with or
without 1mg/mL erythromycin).
MDM Infection
Whole blood was obtained from healthy volunteers. Ethical
approval was granted by South Sheffield Regional
Ethics committee (07/Q2305/7). Peripheral blood mononuclear
cells were separated by differential centrifugation using a Ficoll-
Paque gradient and differentiated into monocyte derived
macrophages (MDM) for 14 d as previously described in 24
well plates (Corning) (26). Bacteria were washed in PBS and re-
suspended in RPMI 1640 supplemented with 10% pooled human
immune serum (from previously vaccinated volunteers
with demonstrable antibody levels to serotype 2 pneumococci)
(27). MDM were chal lenged with either opsonised
S. pneumoniae, Dply or PBS, at a MOI of 10, rested on ice for
1 h and incubated at 37°C in 5% CO2 for a further 3 h (28). For
certain experiments cells were treated with 3 mM vorinostat
(SAHA, Sigma) or 0.5% DMSO (vehicle control) for 30 min prior
to bacterial challenge and vorinostat reintroduced after
bacterial challenge.
S. pneumoniae Internalisation Assay
MDM were challenged with opsonized S. pneumoniae for 3 h
then washed three times in PBS, incubated for 30 min in RPMI
media (Lonza) with 40 units/mL of benzylpenicillin (Sigma) and
20 mg/mL gentamicin (Sanofi). The cells were then washed three
times in PBS and incubated in 250 mL of 2% saponin (Sigma) for
12 min at 37°C in 5% CO2, then 750 mL of PBS was added,
followed by vigorous pipetting. The number of internalised
viable bacteria were measured by counting the number of
colony forming units on Colombia blood agar (CBA) after
24 h incubation at 37°C in 5% CO2 contained in these lysates
measured in triplicate.
Cytokine Measurements
Supernatants were obtained fromMDM challenged with bacteria
and were analysed as per the manufacturers protocol using either
Tumour necrosis factor alpha (TNF-a (Ready-set-go!™,
eBioscience)) or interleukin 6 (IL-6kit (Ready-set-go!™,
eBioscience)). Briefly, 96 well ELISA plates were coated with
100 mL of 1x capture antibody overnight at 4°C, washed, and
blocked in 200 mL assay diluent for 1 h at room temperature.
After a wash, the supernatants were then added as were the
standards (recombinant human TNF-a or recombinant human
IL-6) and incubated for 2 h at room temperature. The wells were
then washed and the detection antibody (biotin-conjugated anti-
human TNF-a or anti-human IL-6) was added. After washing
100 mL avidin-horse radish peroxidase (HRP) was added to
each well for 30 min at room temperature. Plates were then
washed, prior to adding 100uL tetramethylbenzidine substrate
solution for 15 min at room temperature. The reaction was
stopped by adding 2M sulphuric acid, the plate was then read at
450 nm using a Multiskan® EX plate reader (Thermo Scientific),Frontiers in Immunology | www.frontiersin.org 3and the data analysed in GraphPad Prism version 7.0c.
(GraphPad Software).
RNA Extraction
After 3 h of bacterial challenge, cells were washed and lysed in
600 mL Tri Reagent ® (Sigma) for 15 mins at room temperature
before storing at -80 C. Ribonucleic acid (RNA) extraction was
performed following the manufacturers guidelines for Direct-
Zol™ RNA miniPrep (Zymo). Briefly, samples in Tri Reagent®
were centrifuged at 12 000g for 1 min, then the supernatant was
transferred to a fresh 1.5 mL tube, 100% ethanol was added in a
1:1 ratio and well mixed. This was then transferred to the Zymo-
spin™ column, centrifuged for 1 min, then washed using 400 mL
Direct-Zol™ RNA pre-wash, centrifuged again at 12 000g for
1 min, then washed in 700 mL RNA wash buffer and again
centrifuged at 12 000g for 1 min. Finally the RNA was eluted out
in 50µl DNase/RNase free water.
Microarray mRNA Expression Analysis
Affymetrix chip micro-array (Human Genome U133 plus
2.0 array, Santa Clara, CA) analysis of samples from three
individuals was undertaken to characterise gene expression
as previously described (29). Briefly, CEL files were analysed
using R version 3.4.0. CEL files were read using Simpleaffy version
2.52.0 (30); background intensity correction, median correction
and quantile probeset normalisation was performed using robust
multi-array average expression with the help of probe sequence
(GCRMA), using AffyPLM version 1.52.1 (31). The quality
control matrix was generated using Simpleaffy and AffyPLM.
Principal component analysis was performed in R. The probes
whose intensity was within the lowest 20th centile were removed,
using Dplyr version 0.7.1. Differential gene expression was
calculated using Limma version 3.32.2.
Pathway Analysis
Pathway analysis was performed from the differentially-
expressed gene lists generated. Hypergeometric tests were
calculated in R, using GO.db version 3.4.1 to search the Gene
Ontology (GO) database (32) for molecular function, cellular
component, and biological process, using a p value cut off of 0.01
and a minimum of 3 genes. In addition, canonical pathway
analysis was performed using XGR (1.1.5) (33) using all of the
differentially expressed probes identified by ANOVA calculated
in Limma as the test background.
Real Time Quantitative Polymerase Chain
Reaction (RT-qPCR)
The abundance of TNFamRNA in bacterial exposed and mock-
infected MDM was measured using qPCR. To perform cDNA
synthesis a high-capacity cDNA reverse transcription kit
(Applied Biosystems) was used to make complementary DNA
for qPCR assay as per manufacturer’s protocol. The DNA
products were quantified on QuantStudio5 (Abi) using GoTaq
qPCRmaster mix (Promega). The reactions were prepared as per
manufacturer’s protocol.
Fold change was calculated using Delta Delta Ct values.May 2021 | Volume 12 | Article 573266
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Reverse 5' GATATCATCATCCATGGTGAG
CTGG 3'

















Protein lysates were digested with trypsin in conjunction with
the Filter aided separation protocol (FASP) (34). Briefly, cells
were lysed in 150 µL of 4% Sodium dodecyl sulphate (Sigma),
100 mM Tris HCl (Sigma) pH 7.6, 0.1 M Dithiothreitol (Sigma)
and quantified using a BioRad DC assay as per the
manufacturer’s protocol. 100 µg of protein lysates were mixed
with 200 µL of 8 M urea dissolved in triethylammonium
bicarbonate (TEAB) and added to the filter mounted in 11.5
mL low-bind Eppendorf. The tubes were centrifuged at 14 000 g
for 30 min, the flow through discarded and further two 200 µL
washes in 8M urea were performed. Then 100 µL 0.5 M
iodoacetic acid was added for 20 min at room temperature and
then centrifuged at 14 000 g for 30 min. The flow-through was
discarded. The membrane was washed three times with 100 µL of
8 M urea, followed by three washes 100 mM TEAB. The lysates
were trypsin digested overnight at 37°C. The digested proteins
were eluted in 120 µL 100mM TEAB. The samples were then
desalted using Hypersep Hypercarb™ (ThermoScientific) tips
following the manufacturer’s protocol. Briefly, tips were primed
with elution solution (60% Acetonitrile 0.1% TFA) then washed
in 0.1% TFA. The sample was then re-suspended on the tip by
pipetting up and down 50 times. The tip was cleaned in 0.1%
TFA, eluted 60% ACN 0.1% TFA and then 90% ACN 0.1% TFA.Frontiers in Immunology | www.frontiersin.org 4The samples were then dried down in Speedvac (Eppendorf).
The peptides were re-suspended in 0.1%TFA and 3% ACN and
loaded into and run on Ultimate 3000 RSLC nano flow liquid
chromatography system with a PepMap300 C18 trapping
column (Thermo Fisher), coupled to Q-Exactive HF Orbitrap
mass spectrometer (Thermo Fisher). Peptides were eluted onto a
50 cm x 75 mm Easy-spray PepMap C18 column with a flow rate
of 300 nL/min as previously described (35). Peptides were eluted
using a gradient of 3% to 35% solvent B over 75 min. Solvents
were composed of 0.1% formic acid (FA) and either 3%
acetonitrile (ACN) (Solvent A) or 80% ACN (Solvent B). The
loading solvent was 0.1% TFA and 3% ACN. Data acquisition
was performed in full scan positive mode, scanning 375 to
1500m/z, with an MS1 resolution of 120 000, and AGC target
of 1x106. The top 10 most intense ions from MS1 scan were
selected for Collision induced dissociation. MS2 resolution was
of 30 000 with AGC target of 1x105 and maximum fill time of 60
ms, with an isolation window of 2 m/z and scan range of 200-
2000 m/z and normalised collision energy of 27.
MaxQuant Data Analysis
The raw data from the MS were analysed in MaxQuant (version
1.5.6.5). The database search engine Andromeda was used to
search the spectra against the UniProt database. The search
settings were as follows: trypsin/P digestion, with up to 2
missed cleavages, fixed modification was carbamidomethyl (C),
variable modifications were oxidation (M) and acetylation
(Protein N-term), Label Free Quantification (LFQ) was
performed with a minimum number of neighbours of 3 and
average number of neighbour of 6. Peptide tolerance was set at
4.5 ppm and minimum peptide length was set at 7, amino acid
maximum peptide mass was set at 4600 Da and Protein FDR was
set at 0.01. Downstream analysis was performed in R version
3.4.0. The protein identification files were read in, results
matching to a reverse sequence database and or those
matching to a contaminant database were removed as were
those with less than 2 unique peptides. The label-free
intensities were then median-corrected for each sample and
log2 transformed. Differential protein expression was
calculated using Limma version 3.32.2. a repeated measures
ANOVA to enable comparison to the microarray analysis (36).
Histone Extraction
Histone extraction was performed as previously described (37).
Briefly, MDMs were washed in PBS and scrapped in ice cold PBS
with 1x protease inhibitors (Roche Complete EDTA free), before
being pelleted at 900g for 10 min. Cell pellets were lysed in
hypotonic lysis solution then re-suspended in 400 µL 0.2 M
H2SO4. The histones were precipitated out by adding 132uL of
6.1N TCA to the supernatant and washed in acetone then
resuspended in 100 mL of water (HPLC grade). Samples then
underwent chemical derivatisation as previously described (38).
10 mL of 100 mM ammonium bicarbonate pH 8 and 4 ml of
ammonium hydroxide was added to 10 mg of histone sample.
Then 10 mL of propionic anhydride in isopropanol (1:3 ratio) was
added and 100% ammonium hydroxide used to keep the pH >8.0.
The sample was incubated at 37°C for 15 min. Then it wasMay 2021 | Volume 12 | Article 573266
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Eppendorf) and the process repeated. The samples were re-
suspended in 40 mL of 100 mM ammonium bicarbonate and
then tryptically digested overnight. The digestion was stopped by
addition of glacial acetic acid and freezing at -80°C for 5 min.
Finally, the samples were dried down before undergoing a further
two rounds of proprionylation. Hypersep™ Hypercarb™ tip
were used to desalt the samples of the chemical derivatisation
residues following the manufacturer’s protocol for Hypersep ™
Hypercarb ™ (ThermoScientific) (28).
Quantitative MS Analysis of Histone PTMs
The histone samples were re‐suspended in 0.1% trifluoroacetic
acid (TFA) and were analysed on an Ultimate 3000 online nano‐
LC system with a PepMap300 C18 trapping column
(ThermoFisher Scientific), coupled to a Q Exactive HF
Orbitrap (ThermoFisher Scientific). Peptides were eluted onto
a 50 cm × 75 mm Easy‐spray PepMap C18 analytical column at
35°C. Peptides were eluted at a flow rate of 300 nL/min using a
gradient of 3% to 25% over 55 min then 25% to 60% until 81 min.
Solvents were composed of 0.1% formic acid (FA) and either 3%
acetonitrile (ACN) (solvent A) or 80% ACN (solvent B). The
loading solvent was 0.1% TFA and 3% ACN run in Data
independent acquisition as previously described (35). The
PTM identification and relative abundance was performed in
Skyline and Epiprofile 2.0 also as previously described (35).
Western Blot Analysis
Whole cell lysates were obtained using Laemmli buffer. Samples
were separated by SDS-PAGE (12%) and blotted onto poly-
vinylidene difluoride (PVDF) membranes (Bio-Rad
Laboratories). Blots were incubated overnight at 4°C with
antibodies against Actin (Rabbit polyclonal, Sigma-Aldrich) or
PTGS2 (Rabbit polyclonal, Cell Signalling). Protein detection
was carried out with horseradish peroxidase (HRP)-conjugated
secondary antibodies, goat anti-rabbit IgG (Dako, P0448, 1:2500)
and ECL substrate (GE Healthcare). Bands were quantified using
Image J 1.32 software (v1.8, NIH). The intensity ratio of PTGS2
and actin, were calculated and normalised to the Mock
infected samples.
Metabolic Measurements
The metabolic measurements were performed as previously
described (39). Briefly, 14 day old MDM were re-seeded in
XF24 cell plates (Agilent Technologies) at 150,000 MDMs/well.
Cultures were then challenged with bacteria or mock-infected
were washed twice with XF medium supplemented with 4.5 g/L
D-glucose, 2.0 mM L-glutamine, 1.0 mM sodium-pyruvate, 100
U/L penicillin and 100 mg/mL streptomycin at pH 7.4 (adjusted
with 1.0 M NaOH). Next 630 mL modified XF medium was
added to each well and incubated for 1 h at 37·C without CO2.
70 mL oligomycin A (15 mM), 77 mL FCCP (20 mM) and 85 mL
rotenone (10 mM) plus antimycin A (10 mM) (Sigma-Aldrich)
were added to the cartridge injection ports A, B and C,
respectively and incubated for 1 h at 37°C without CO2. The
plate was loaded into the XF24 analyser (Seahorse, AgilentFrontiers in Immunology | www.frontiersin.org 5Technologies). After equilibration, the cartridge containing
the oxygen sensor, measuring the oxygen consumption rate
(OCR) and the cartridge containing the proton sensor,
measuring the extracellular acidification rate (ECAR) kinetics
were run before and after injecting oligomycin, FCCP and
rotenone plus antimycin A, respectively. Data were normalized
by total protein.
DCFDA Assay
For the measurement of reactive oxygen species (ROS) MDMs
were washed with PBS three times and incubated in fresh media
with the addition of 20 mM 2′,7′-Dichlorofluorescin diacetate
(DCFDA, Sigma) for 30min at 37 °C with 5% CO2 then washed
three times in PBS before being challenged with opsonised
Streptococcus pneumoniae at an MOI of 10 for 3 hours. The
cells were then washed 3 times in PBS and resuspended in 500 mL
prior to analysis. Samples were run on an 4 colour
FACSCalibur™ (BD Biosciences) using CellQuest Pro version.
10 000 gated events were counted and Forward (FSC) and Side
scatter (SCC) were used to define populations. Data analysis was
performed in FlowJo™ software (version 10.1r5).
Statistical Analysis
Statistical analysis was performed using either R for the
microarray and proteomic analysis, or for all other
experiments in Prism version 7.0c (Graphpad). Data is
presented as standard deviation (SD) or standard error of the
mean (SEM). For all experiments a minimum of 3 biological
replicates was used. Comparison between two paired groups
employed a paired t-test, for comparison of 3 or more conditions
a one-way analysis of variance (ANOVA) with Tukey’s post-test
was performed. For comparison of multiple observations in more
than two groups a two-way ANOVA with Tukey’s multiple
comparison post-test was performed.RESULTS
Pneumolysin Shapes the Macrophage
Transcriptome in Response to
Pneumococci
Transcriptional responses to Gram-positive bacteria occur rapidly
and are well developed after three hours of bacterial challenge
(15, 18). Therefore, we initially analysed transcriptional changes
in monocyte-derived macrophages (MDMs) three hours after
bacterial challenge with either wild-type or a pneumolysin
deficient (Dply) strain. We confirmed that intracellular viability
of pneumococci was equivalent at this time between wild-type
and Dply strains (Supplemental Figure S1), thereby excluding
potential confounding by different levels of vita-pathogen-
associated molecular pattern (40).
We identified 1872 probe-sets that were differentially
expressed in response to bacterial challenge with either strain
(F value <0.05) and 1553 after multiple test correction false
discovery rate (FDR <0.05) (Supplemental Table S1). Next, we
calculated moderated t tests for each infection, as shown in theMay 2021 | Volume 12 | Article 573266
Cole et al. Epigenomic Study of Pneumolysin in MacrophagesVolcano plots in Figure 1. The analysis identified 503 probe-sets,
which are differentially expressed in a pneumolysin-dependent
manner, 506 in an independent manner and 234 only in the
absence of pneumolysin (summarised Supplemental Figure S2
and Figure 2). Of the 503 probe-sets differentially expressed in a
pneumolysin dependent manner 131 were upregulated and 372
down regulated. The 10 upregulated probes with the highest fold
changes included fatty acid binding protein 4 (FABP4) involved
in cytokine production, and two members of the TNF receptor
superfamily (TNFRSF 9 and 4) involved in the host immune
response, and interleukin 1 receptor antagonist (IL1RN) involved
in signal transduction (Supplemental Table S2). The 234 genes
only differentially expressed in the absence of pneumolysin
include 96 downregulated probe-sets and 138 upregulated
ones. Of the downregulated probes with the 10 highest fold
changes four related to DNA binding, LYL1, basic helix-loop-
helix family member (LYL1), MIS18 binding protein 1
(MIS18BP1), ZFP36 ring finger protein like 2 (ZFP36L2) and
nuclear factor of activated T cells 1 (NFATC1). Of the
upregulated probes with the highest fold change there were
several probes involved in inflammatory responses, cytokine
and chemokine signalling such as C-X-C motif chemokine
ligand (CXCL) -1, and 3, as well as interleukin 1 beta and
alpha (Supplemental Table S2). Finally, 506 probe-sets were
differentially expressed in response to either strain. The probes
coding for TNF, prostaglandin- endoperoxide synthase 2
(PTGS2) and nuclear receptor subfamily 4 group A member 3
(NR4A3) as well as the CXCL8 probe were amongst the 10
upregulated probes with the highest fold change. The
downregulated probes included several members of the
GTPase IMAP family (GIMAP1 and 6).
To provide further insight into the transcriptional responses
in MDMs following bacterial challenge we undertook pathway
analysis of the differentially expressed genes.Frontiers in Immunology | www.frontiersin.org 6Pathway Analysis of Differentially
Expressed Genes
Gene Ontology (GO) pathway analysis demonstrated that the
top ten enriched terms in the MDMs challenged with S.
pneumoniae were predominantly related to cell metabolism
(Supplemental Figure S3 and Supplemental Table S3). As we
have previously identified changes in the oxidative stress
response in alveolar macrophages in response to challenge with
Streptococcus pneumoniae (29) we were also interested in the fact
that there were a number of terms relating to cellular responses
to “stress” [17 in the S. pneumoniae challenge and 15 in the Dply
mutant (Supplemental Table S3)] and in particular to oxidative
stress responses. The differentially expressed genes belonging
to the GO term for oxidative stress response were highlighted
for each strain (Figure 1 and Supplemental Table S4).
These results highlighted that the differentially expressed genes
were predominantly upregulated. Moreover, the TNF, heme
oxygenase 1 (HMOX1) and prostaglandin-endoperoxide
synthase 2 (PTGS2) genes were strongly upregulated. In order
to validate the results of the microarray experiment we measured
the levels of mRNA for TNF, C-JUN, IL1RN, PTGS2 and NR4A2
by qPCR in separate biological replicate (Figure 3). This
demonstrated that pneumolysin not only blunted the TNF
response but also PTGS2 expression. Furthermore, we show
that following challenge with S. pneumoniae MDM generate
reactive oxygen species and leads to alterations in oxidative
metabolism (Supplemental Figure S4).
In addition to performing Gene ontology analysis we also
analysed the differentially expressed genes using eXploring
Genomic Relations (XGR), which performs hypergeometric
enrichment analysis with background correction using the
expression of monocyte derived macrophage cells to give a
more cell type specific analysis. Canonical pathway analysis
was performed for genes whose expression was upregulated byA B C
FIGURE 1 | Oxidative stress response pathway terms significantly upregulated. Monocyte derived macrophages (MDMs) were challenged with either S.
pneumoniae, the isogenic pneumolysin negative mutant (Dply) or mock infected with phosphate buffered saline (MI) in biological replicates of three. After 3 h
incubation the gene expression was measured using Affymetrix arrays. (A) volcano plots comparing log2 (fold change) to log10 p value for MI vs S. pneumoniae
challenged MDMs. (B) volcano plots comparing log2 (fold change) to log10 p value for MI vs Dply challenged MDMs. (C) volcano plots comparing log2 (fold change)
to log10 p value for S. pneumoniae vs Dply challenged MDMs. The highlighted genes belong to the Oxidative stress response Gene Ontology term and are
significantly expressed (q value <0.05). In red are those found in challenge with both strains, in blue the genes that are only found in the response to Dply challenge
and in orange the pneumolysin-dependent genes found after S. pneumoniae but not Dply.May 2021 | Volume 12 | Article 573266
Cole et al. Epigenomic Study of Pneumolysin in Macrophagesgreater than 2-fold in response to challenge with S. pneumoniae
(adjusted p value <0.05). This revealed 36 over-represented
pathways (Supplemental Table S5). Importantly this
demonstrated that both the TNF and the NFkB signalling
pathways were enriched. Analysis of the 2-fold downregulated
terms did not reveal any enriched canonical pathways.
The analysis of the differentially expressed genes whose
expression was up-regulated by greater than 2-fold in response
to challenge with the Dplymutant also revealed that the pathways
for TNF, NFkB and CD40 signalling were significantly over-
represented (Supplemental Table S6). This highlights the
importance of these pathways in the response to bacterial
challenge. It also suggests that the increase in pro-
inflammatory signals being released in particular TNF is
independent of ply. Of note, we observed a 64-fold increase in
the TNF mRNA in response to the Dply mutant strain but only
16-fold increase in response to the parent strain (Figure 1).Frontiers in Immunology | www.frontiersin.org 7Additionally, pathway analysis was performed for genes
identified by ANOVA as differentially expressed in between the
both bacterial challenges (p value <0.05) (Supplemental Table
S7). This revealed the overrepresentation of a number of
signalling pathways such as the ERK1/ERK2 MAPK pathway,
integrin-linked kinase signalling, signalling events mediated by
PTP1B, SHP2 signalling and Fas signalling pathway. in addition
the ATF-2 transcription factor network was overrepresented.
Next we performed the GO term analysis on these differentially
expressed genes and among the overrepresented terms, we
identified histone acetylation, chromatin organisation, and
cellular response to oxidative stress (Supplemental Table S7).
Label-Free Quantitative Proteomic
Analysis
Having established that there was a transcriptional difference in
the host cell response following challenge with S. pneumoniae orFIGURE 2 | Heatmap of the differentially expressed probes following MDM challenge. Monocyte derived macrophages (MDMs) were challenged with either
S. pneumoniae, the isogenic pneumolysin negative mutant (Dply) or mock-infected with phosphate buffered saline (MI) in biological replicates of three. At 3 h the
gene expression was measured using Affymetrix arrays. This heatmap represents genes found to be differentially expressed (one-way ANOVA, with F p value <0.05).May 2021 | Volume 12 | Article 573266
Cole et al. Epigenomic Study of Pneumolysin in MacrophagesDply, further studies were performed to examine the effects of S.
pneumoniae on the proteome of MDMs.
Label free quantitative mass spectrometry was used to identify
differentially expressed proteins following challenge with S.
pneumoniae or Dply. We identified 1807 proteins in samples
challenged with S. pneumoniae and 1862 in those challenged
with Dply. On average we identified 1812 proteins in each of the
12 samples from 4 biological replicates that we analysed. Of
these, we identified 30 that were differentially expressed between
the three conditions with an F statistic value of less than 0.05
(summarised in Table 1). The results show that 16 proteins
are differentially expressed in response to infections with S
pneumoniae, and 22 in response to Dply. Of the differentially
expressed proteins common to both bacterial challenges
were Prostaglandin G/H synthase 1 (PTGS1), which is
involved with PTGS2 in the production of inflammatory
prostaglandins, and Galectin 3-binding protein, which is
involved in initiating signalling cascades. In addition the
proteins Phosphoglucomutase-1 glucose which participates in
breakdown of glucose and Complex III assembly factor LYRM7
which is a mitochondrial chaperone were both differentially
expressed highlighting the importance of metabolism in
response to infection as illustrated by the microarray pathway
analysis results. In addition, although the concordance betweenFrontiers in Immunology | www.frontiersin.org 8transcripts and proteins is generally poor, we observed that
both the transcript and the protein abundance for the vacuolar
protein sorting 13 C protein (VPS13C), which is associated with
mitochondrial function, were differentially expressed.
We were able to measure the relative abundance of PTGS2
by Western blotting to confirm that these prostaglandin
pathways were upregulated by challenge with S. pneumoniae
and Dply (Figure 3). Furthermore, there was significantly more
PTGS2 in response to challenge with Dply, suggesting that
pneumolysin was responsible for blunting of the inflammatory
response as was observed with the transcriptomic analysis
(Figure 3).
Eight proteins were differentially expressed in a pneumolysin-
dependent manner, these included serine/threonine protein
kinase, oxidative stress response 1 protein (OXSR1) and
ubiquitin domain-containing protein 1/2 (UBTD2), and 9 were
common to both bacterial strains, including Galectin 3 binding
protein which is involved in the host immune responses (41) and
the 26S proteasome non-ATPase regulatory subunit 5 (PSMD5).
Several of the differentially expressed proteins identified such as
PSMD5, UBTD2 and Ubiquitin conjugation factor E4 A
(UBE4A) are involved in protein turnover involving a number
of pathways known to be important in the regulation of host
immune responses (42).TABLE 1 | Differentially expressed proteins at 6 h following challenge with S pneumoniae or Dply.
MI vs S pneumoniae MI vs Dply
protein name Gene name logFC adj.P.Val logFC adj.P.Val
Prostaglandin G/H synthase 1 PTGS1 -2.83 6.42E-03 -1.67 2.60E-02
Serine/threonine-protein kinase OSR1 OXSR1 -2.36 3.82E-04 -1.03 5.59E-02
Probable global transcription activator SNF2L2/Transcription activator BRG1 SMARCA2/SMARCA 4 -3.69 3.85E-04 -0.60 4.99E-01
Galectin-3-binding protein LGALS3BP -2.36 1.26E-03 -1.94 2.96E-03
Ubiquitin domain-containing protein 1/2 UBTD2 2.84 2.48E-03 0.68 2.95E-01
Phosphoglucomutase-1 PGM1 -2.19 1.42E-02 -2.69 8.14E-04
Vacuolar protein sorting-associated protein 13C VPS13C -1.83 6.42E-03 -2.06 1.04E-03
Unconventional myosin-Ixb MYOB9B -1.27 4.09E-02 -2.05 1.13E-02
Probable ATP-dependent RNA helicase DDX46 DDX46 1.69 6.42E-03 0.65 2.15E-01
Probable 28S rRNA (cytosine (4447)-C (5))-methyltransferase NOP2 1.62 6.42E-03 0.06 9.32E-01
Coiled-coil domain-containing protein 22 CCDC22 2.54 1.23E-02 0.99 1.92E-01
Sorting nexin-8 SNX8 1.63 2.47E-02 -1.22 3.36E-02
Complex III assembly factor LYRM7 LYRM7 1.66 1.28E-02 1.47 9.57E-03
Motile sperm domain-containing protein 2 MOSPD2 -1.29 1.57E-02 -0.04 9.32E-01
Spectrin beta chain, non-erythrocytic 1 SPTBN1 2.52 6.42E-03 2.02 4.05E-03
6-phosphogluconolactonase PGLS -1.18 2.47E-02 -0.06 9.32E-01
26S proteasome non-ATPase regulatory subunit 5 PSMD5 2.76 6.14E-05 1.90 1.66E-03
Ubiquitin conjugation factor E4 A UBE4A -1.69 8.34E-02 3.92 7.72E-04
N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 DDAH2 -1.48 5.88E-02 -2.13 1.09E-03
Threonine–tRNA ligase, cytoplasmic TARS -1.42 6.93E-02 -2.12 9.57E-03
Haloacid dehalogenase-like hydrolase domain-containing 5 HDHD5 -0.87 2.62E-01 -2.79 1.09E-03
Protein canopy homolog 2 CNPY2 -0.88 8.56E-02 0.67 1.92E-01
Mitochondrial carrier homolog 1 MTCH1 -0.87 1.08E-01 -2.88 3.75E-04
eIF-2-alpha kinase activator GCN1 GCN1 -0.74 1.91E-01 -1.79 1.66E-03
Deoxyribonuclease-2-alpha DNASE2 -0.65 1.18E-01 0.09 9.00E-01
2’-deoxynucleoside 5’-phosphate N-hydrolase 1 DNPH1 -0.25 7.52E-01 -2.74 1.09E-03
Piezo-type mechanosensitive ion channel component 1 PIEZO1 0.23 7.61E-01 -2.36 1.04E-03
Nuclear pore complex protein Nup155 NUP155 0.39 6.29E-01 2.01 3.27E-03
40S ribosomal protein S15a RPS15A 0.46 2.68E-01 1.09 1.20E-02
Methylmalonic aciduria type A protein, mitochondrial MMAA 0.71 2.13E-01 1.94 1.66E-03May 2021 | Volume 12 | ArticProteins in bold and black are differentially expressed in response to challenge with both strains of bacteria, in red are highlighted the proteins only differentially expressed in response to
challenge with Dply and in blue are those that are only differentially expressed in response to challenge with Streptococcus pneumoniae.le 573266
Cole et al. Epigenomic Study of Pneumolysin in MacrophagesPneumolysin Is Responsible for Changes
in the Relative Abundance of Histone
Post-Translational Modifications
Having defined a pneumolysin-dependent alteration of the
macrophage transcriptome and proteome in response to S.Frontiers in Immunology | www.frontiersin.org 9pneumoniae, we sought next to establish if ply also influenced
epigenetic changes in response to S. pneumoniae. Quantitative
mass spectrometry was used to identify changes in the global
abundance of histone PTMs following challenge with





FIGURE 3 | Pneumolysin leads to repression TNF and PTGS2 production. Monocyte derived macrophages (MDMs) were challenged with either S. pneumoniae, the
isogenic pneumolysin negative mutant (Dply), or mock-infected with phosphate buffered saline (MI). After 3 h incubation RNA was extracted from MDMs and RT-
qPCR performed to measure the abundance of (A) TNF, (B) PTGS2, (C) C-JUN, (D) IL1RN and (G) NR4A2 mRNA. The Bar chart represents the DDCT fold change
for each bacterial challenge demonstrating significantly higher abundance of TNF, PTGS2, C-JUN and IL1RN mRNA following challenge with Dply. (G) There was no
significant difference in the abundance of NR4A2 mRNA in response to either bacterial challenge. (E) A representative western blot after probing with anti-PTGS2
antibody is shown, with actin used as a loading control. The blot is representative of four independent experiments. (F) Densitometry was performed to estimate the
PTGS2/actin and normalised to mock infected sample. The bar charts represent mean and Standard Deviation, n= 10 for panel (A, B). n=6 for panel (C) and n=7 for
panel (D, G); *p < 0.05, **p < 0.01.May 2021 | Volume 12 | Article 573266
Cole et al. Epigenomic Study of Pneumolysin in MacrophagesPTMs, methylation and acetylation, on histones H3 and H4, in
MDMs in response to bacterial challenge we identified 94
different peptide proteoforms and 18 were found to change in
response to bacterial challenge (Figure 4). A subset of these
changes were ply-dependent, since they were significantly altered
in S. pneumoniae in comparison to the Dply mutant
(Supplemental Table S8). These included significant increases
in the relative abundance of H3K4me1 and H3.3K36me2
following challenge with S. pneumoniae in comparison to Dply.
In addition, we observed decreases in the relative abundance of
H3K9me2, H3K27me2 and H3K79me2 in a pneumolysin-
dependent manner compared to both mock infected (MI; blue)
and Dply (Figure 4). Moreover, there was a pneumococcal
associated ply-independent increase in the level of H3K27me2
K36me2 and a reciprocal drop in H3K27me3K36me1. We noted
an increase in the relative abundance of H3.3K36me2 in a ply
dependent manner and an increase in the relative abundance
of H3K23ac and an increase in H3.3K27me2K36me1 with a
reciprocal drop in H3.3K27me2K36me2 in response to both
bacterial challenges.
Further analysis of histone H4 showed a significant increase
in the abundance of acetylation on K16 (H4K16ac) in response
to infection with either strain (Figure 4). In addition, there was
also a decrease in the dimethylated form of K20 (H4K20me2)
and a reciprocal increase in the monomethylated form
(H4K20me1) in a pneumolysin-dependent manner.
Pneumolysin Blunts Inflammatory
Signalling During Early Infection
In order to establish the consequences of these changes to the
transcriptome and epigenome, we next selected one prominent
immune signature regulated by pneumolysin, TNF-a expression,
and established this as a key component of the early immune
response to S. pneumoniae (43). Using qRT-PCR we measured
the abundance of TNFa mRNA in infected MDMs. There was a
significant increase in the TNFamRNA level following infection
with the ply deficient mutant but not the parent strain or the
reconstituted mutant (Figure 5A). Next, we measured the
amount of secreted of TNFa in MDM supernatants following
3 h of bacterial challenge (Figure 5B). We found that TNFa
levels were significantly higher following challenge with the Dply
mutant suggesting that ply initially blunts TNF-a expression.
Finally, we measured the concentration of TNFa and IL-6
over time using ELISA assays to determine if this initial anti-
inflammatory effect was maintained (Figure 5C). The results
showed that the difference seen in the release of TNF-a, was only
observed at an early time window, 3-5 h after exposure to
bacteria. In addition there was a similar trend observed with
the inflammatory cytokine IL-6. This suggests that the anti-
inflammatory effect of pneumolysin only plays a role over a
defined time period.
Histone Deacetylase Inhibitors Reduce
TNFa Cytokines in Response to Infection
Having previously demonstrated that pneumolysin both modifies
macrophage transcriptome and epigenome we next tested ifFrontiers in Immunology | www.frontiersin.org 10epigenetic modifications could alter key ply-associated immune
responses. As a proof of concept, we pre-treated MDMs with the
histone deacetylase inhibitor (HDACi) vorinostat (SAHA) or
vehicle control (DMSO) following challenge with Streptococcus
pneumoniae or Dply mutant and quantified TNFa release (Figure
6). As previously shown, challenge with the Dply mutant strain
resulted in significantly increased TNFa levels as compared to the
parental strain, but this level was significantly decreased in the Dply
mutant challenged cells by pre-treatment with vorinostat. This
suggests that the epigenetic modifications we observed as being
induced by ply exposure could have functional consequences to
immune responses, as illustrated for TNF.DISCUSSION
Using a range of systems level approaches we have demonstrated
that pneumolysin exerts a strong influence over the host response to
S. pneumoniae at the transcriptomic, proteomic and epigenetic level.
We have shown that 503 probes were differentially expressed in
pneumolysin-dependent manner in association with global
modifications in histone PTMs. These changes are associated with
widespread changes in macrophage metabolism, oxidative stress
responses and cytokine signalling and result in differential
expression of key immune proteins, including TNF-a and IL-6.
Crucially we show that use of a HDAC inhibitor to modify the
epigenome is sufficient to reprise the reduction in TNF identified as
occurring in response to pneumolysin.
Our results on the transcriptional response of macrophages to
pneumolysin are consistent with previous transcriptomic analysis in
undifferentiated THP-1 cells that showed 142 genes to be
differentially expressed in a ply dependent manner and 40 to be
ply independent (15). Our study in primary cells, identifies many
more genes differentially regulated enabling more in-depth analysis
of changes at a pathway level. A number of differentially expressed
genes are involved in the immune response such as TNF and
HMOX1. Pathway analysis of the differentially expressed probes
highlighted the importance of metabolic pathways in response to
infection, and in particular the role for oxidative stress responses.
The host’s oxidative stress responses have been highlighted as
playing a key role in the host response to S pneumoniae in lung
epithelial cells (44). Importantly, this module is upregulated in
alveolar macrophages (AM) and plays a key role in preserving
responses such as phagocytosis which may otherwise be altered by
dysregulated oxidative stress in AM and MDM (7, 45).
Furthermore, nuclear factor erythroid 2 (NRF2) plays a pivotal
role in the protection against lung injury (46), reduces lung
inflammation after intratracheal instillation of LPS and decreases
mortality in systemic models of inflammation (47). Crucially,
NRF2-regulated pathways are amenable to therapeutic
manipulation as evidenced by improved AM phagocytosis in
patients with chronic obstructive pulmonary disease following ex
vivo treatment with NRF2 agonists and also in a mouse model of
cigarette smoke associated impairment of bacterial clearance in the
lung (48). The XGR pathway analysis following bacterial challenge
further highlighted NFkB, NOD-like receptor and TNF signalling asMay 2021 | Volume 12 | Article 573266
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FIGURE 4 | Pneumolysin is responsible for changes in relative abundance of PTMs on histone H3 and H4. Monocyte derived macrophages (MDMs) were
challenged with either S. pneumoniae, the isogenic pneumolysin negative mutant (Dply) or mock infected with phosphate buffered saline (MI) in biological replicates of
three. After 3 h incubation the histones were extracted and analysed by mass spectrometry and the relative abundance of each post translational modification (PTM)
was measured for each peptide. The bar plots represent the relative abundance of each PTM quantified, blue represents the abundance in MI MDMs, green
following challenge with S. pneumoniae and in red to Dply. (A) Peptide TKQTAR shows an increase in the level of H3K4me1. (B) Peptide KSTGGKAPR shows a
decrease in the level of H3K9me2 in a pneumolysin-dependent manner. (C) Peptide KQLATKAAR shows a relative increase in the level of H3K23ac in response to
both bacterial challenges. (D) Peptide KSAPATGGVKKPHR shows a decrease in H3K27me2 following challenge with S. pneumoniae compared to MI, an increase in
the level of H3K27me2K36me2 and a reciprocal drop in H3K27me3K36me1 in response to Dply challenge compared to MI. (E) Peptide EIAQDFKTDLR shows an
increase in the relative abundance of H3K79me2 following challenge with Dply. (F) Peptide KSAPSTGGVKKPHR of H3.3 shows an increase in H3.3K36me2 and in
H3.3K27me2K36me1 with a reciprocal drop in H3.3K27me2K36me2. (One-way ANOVA, *p < 0.05, **p < 0.01, ***p < 0.001, error bars represent mean and
standard deviation). (G) Peptide GKGGKGLGKGGAKR shows a relative increase in the level of H4K16ac following challenge with S. pneumoniae in comparison to
the Dply. (H) Peptide KVLR shows a decrease in the level of H4K20me2 in a pneumolysin-dependent manner compared and a reciprocal increase in the
H4K20me1. Conversely for the MDM challenged with Dply there was a rise in H4K20me2 and a fall in the level of H4K20me1. (n=3. One way ANOVA, *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001).
Cole et al. Epigenomic Study of Pneumolysin in Macrophagesenriched pathways emphasising their importance in the host’s
response to bacteria.
The label-free quantitative proteomic analysis revealed a
small number of significantly differentially expressed proteins,
but substantiated involvement of several of the pathways
identified at the transcriptomic pathway level. Examples of
proteins linked to these pathways included an increase in the
coiled-coil domain containing protein 22 (CCDC22), that plays
an essential role in NFkB signalling and whose depletion leads to
blockade of signalling (48, 49). We also noted downregulation of
the oxidative stress response protein 1 (OXSR1) involved in the
oxidative stress response (50) in a ply-dependent manner.
The quantitative proteomic analysis identified a number of
pneumolysin-dependent differentially expressed proteinsFrontiers in Immunology | www.frontiersin.org 12involved in the regulation of gene transcription, protein
translation, and modulation of signalling pathways such as the
NFkB pathway, which are predicted to regulate innate immune
responses to bacteria.
Finally, the quantitative mass spectrometry analysis of histone
PTMs in response to S pneumoniae was used to identify and
quantify 94 different peptide proteoforms. Of these, there were 5
whose relative abundance changed in a pneumolysin dependent
manner. This is to our knowledge the first time that this approach
has been applied to study the changes in relative abundance of
histone PTMs in primaryMDMs in response to S. pneumoniae. The
advantages of mass spectrometry analysis used in this study were
emphasised by the identification of combinatorial marks on both
H3 and H3.3 that would not have been possible using antibody-A B
C
FIGURE 5 | Pneumolysin leads to blunted TNFa release by repressing mRNA production. Monocyte derived macrophages (MDMs) were challenged with either S.
pneumoniae, the isogenic pneumolysin negative mutant (Dply), the isogenic pneumolysin negative mutant with reconstituted pneumolysin (ply-Dply). or mock-infected
with phosphate buffered saline (MI). (A) After 3 h incubation RNA was extracted from MDMs and RT-qPCR performed to measure the abundance of TNFa mRNA.
The Bar chart represents the DCT fold change for each bacterial challenge demonstrating significantly higher abundance of TNFa mRNA following challenge with
Dply. (n= 6 One-way ANOVA F statistic =0.01 and p value <0.05. (B) At 3 h TNFa concentration were measured in the supernatants of MDMs challenged with each
strain. The Bar chart demonstrate the significantly raised level of TNFa in response to challenge with △ply (n=8, one way ANOVA F statistic = 0.0011, p<0.05).
(C) TNFa and IL-6 cytokines were measured in supernatants following challenge with S. pneumoniae or △ply at 0.5, 1, 2, 3, 4, 5, 6, 7 h. The bar charts represent
mean and Standard Deviation of 3 biological replicates run in technical duplicates are shown demonstrating a significant difference in the rise of TNF-a between the
two strains at 4 h, (black line highlights differences between control and Dply, red line between control and S pneumoniae, blue line S pneumoniae, and Dply,
*p < 0.05, **p < 0.01, ****p < 0.0001).May 2021 | Volume 12 | Article 573266
Cole et al. Epigenomic Study of Pneumolysin in Macrophagesbased approaches. Interestingly several of these modifications are
associated with activating or repressing gene transcription.
Although some histone PTMs are well characterised in a number
of systems, their exact function in the context of infections is yet to
be fully described. It is likely to vary between cell types.
Furthermore, individual PTMs will not act in isolation but rather
be part of a combinatorial code fine tuning responses to
environmental stressors, such as to bacterial infection and at later
time points after exposure to consequences such as DNA damage.
Nevertheless, in light of the changes observed in response to
challenge with S. pneumoniae (e.g. increases in H3K4me1,
H3K23ac or H4K16ac and decreases in H3K9me2 or H3K79me2)
it is possible that these changes represent the removal of repressive
marks and the increase in marks associated with active gene
transcription allowing fine tuning of the innate immune host
response to bacteria to occur. This highlights the important role
played by PTMs in the response to infection and therefore offer the
potential for the novel use of therapeutic approaches involving
immunomodulation of host responses. However, our current study
does not establish a direct connection between the histone PTMs
and the functional consequences identified. Future work to identify
these such as Chromatin Immunoprecipitation and sequencing will
enable the integration of histone PTMs changes at the gene level and
in combination with further work to explore the epigeneticFrontiers in Immunology | www.frontiersin.org 13regulation of the oxidative response and cellular metabolism in
response to infection may allow the development of more targeted
approach to immunomodulation.
The functional consequences of the net changes to
transcriptional responses involving inflammatory cell signalling
and regulation of protein expression were examined focusing on
TNF-a as an exemplar early response cytokine that plays a key role
against S. pneumoniae (43). We selected this cytokine since ply
induced a significant temporal reduction in production of TNF-a,
in conjunction with decreased production of IL-6. Our
demonstration that pneumolysin inhibits the early production
of TNF-a is consistent with the findings others have reported
in dendritic cells and murine AM (16). We were able to
demonstrate that changes in the epigenetic landscape are
sufficient to reverse the maximal induction of TNF-a production
observed following challenge with the ply-deficient mutant. These
experiments, using a HDACi, suggest that blunting of TNF-a
release by MDM following challenge with a pneumococcal strain
expressing ply could be mediated through epigenetic mechanisms.
This is important since early response cytokine generation is critical
to the outcome of infection in S. pneumoniae and any modulation
through reshaping the epigenetic landscape would be anticipated to
have major consequences to the outcome of infection. Of note, the
HDAC inhibitor Cambinol has been shown to inhibit TNF and IL-6
secretion in bone marrow-derived macrophages stimulated with
LPS and was associated with greater survival in a murine lethal
endotoxemia model and in response to Klebsiella pneumoniae
challenge (51). In this case the therapeutic intervention was
thought to limit excessive cytokine responses whereas in the case
of ply we would suggest it may limit early cytokine responses
required to enhance early pathogen control. This emphasizes that in
line with other aspects of host modulation through epigenetic
manipulation would require careful calibration.
In summary our findings using a range of systems levels
approaches show that pneumolysin modifies the early host
response of macrophages to S. pneumoniae through
modification of inflammatory responses, resistance to oxidative
stress and metabolic responses. We observe that these
transcriptional responses and the differential protein expression
are associated with global changes in histone PTMs. We show
alteration of the epigenetic landscape has functional consequences
to key immune responses such as TNF-a production and suggest
that ply exerts these effects through epigenetic modulation and
regulation of histone acetylation status. Our results also hint at a
potential route by which these early host responses can be altered
to improve responses to infection through the use of agents that
modulate the enzymes that induce the signature pathogen-
mediated epigenetic marks that adversely impact host responses.DATA AVAILABILITY STATEMENT
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Supplementary Figure 1 | Viable intracellular bacteria following 3 h challenge
with S. pneumoniae, Dply or ply-Dply mutants. Monocyte derived macrophagesFrontiers in Immunology | www.frontiersin.org 14(MDMs) were challenged with either S. pneumoniae, the isogenic pneumolysin
negative mutant (Dply) or the isogenic pneumolysin negative mutant with
reconstituted pneumolysin (ply-Dply). At 3 h the number of viable intracellular
bacteria was determined. The results are expressed as mean and log10 of cfu/mL
and represented as bar chart with standard deviation. (n=3, one way ANOVA
p=0.99)
Supplementary Figure 2 | Venn Diagram representing the overlap in differentially
expressed genes.
Supplementary Figure 3 | Gene ontology biological processes enriched terms
show stress responses and metabolism are over-represented. Monocyte derived
macrophages (MDMs) were challenged with either S. pneumoniae, the isogenic
pneumolysin negative mutant (Dply) or mock-infected with phosphate buffered
saline (MI) in biological replicates of three. At 3 h the gene expression was measured
using Affymetrix arrays. The bubble plot shows the top ten enriched Gene Ontology
(GO) biological processes terms in both the pneumolysin mutant and the parental
strain analysis. The bubble size and colour correspond to the number of genes that
have mapped to the GO term. The bubbles are plotted along the x axis according to
the –log10 p value for the enrichment.
Supplementary Figure 4 | Metabolic profile of MDMs following S. pneumoniae
challenge. MDMs were challenged with S. pneumoniae or mock-infected with
phosphate buffered saline (MI) in four biological replicates for 3 hours. The
extracellular acidification rate (ECAR) and mitochondrial oxygen consumption
rate (OCR) was measured by the Seahorse X24 extracellular flux analyser.
(A) representative plots for the OCR kinetic data (B) basal OCR, (C) maximum
respiration capacity, (D) DCFDA Reactive Oxygen Species measured by flow
cytometry. Data are shown as mean ± SD, n=4. Paired t test, *p<0.05. **p<0.01
***p<0.001
Supplementary Table 2 | 10 highest up-regulated and 10 down-regulated
differentially expressed probes following challenge of MDMswith eitherS. pneumoniae
or dply. Differentially expressed probes referenced in the text are highlighted in bold.
Supplementary Table 3 | Gene Ontology Biological Processes pathway analysis
of up-regulated differentially expressed probes following challenge of MDMs either
S. pneumoniae or Dply. Gene Ontology pathways of interest that are referenced in
the text are highlighted in bold.
Supplementary Table 4 | Summary of differentially expressed genes related to
the Oxidative stress GO term. In bold are the terms TNF, PTGS2 and HMOX1
referenced in the text.
Supplementary Table 5 | Canonical pathway analysis of up-regulated differentially
expressed probes following challenge of MDMswith S. pneumoniae using XGR. In bold
are the TNF and NF-KB pathways referenced in the text.” to the legend for table S5.
Supplementary Table 7 | Canonical and GO Biological processes pathway
analysis of differentially expressed probes between both bacterial challenges. In
bold are the Gene Ontology terms (histone acetylation, cellular response to
oxidative stress and chromatin organisation) referenced in the text.REFERENCES
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